Financing channel feed – Endpoints News

Financing channel feed

RA Capital backs a Philly biotech's $118M crossover as it aims to break into the hypertension space

3 years ago

Seeking to 'close the loop' in drug discovery with machine learning, Catalio-backed biotech emerges from semi-stealth

3 years ago

Latent or lytic infection? Doesn't matter, Danish biotech says for transplant-related cytomegalovirus drug

3 years ago

German startup jumps into the hot radiopharma space with a former Ipsen compound as lead program

3 years ago

A former Merck director's Pfizer-backed biotech will take on his old bosses in nascent LILRB field

3 years ago

Gene therapy biotech looking to bypass viral delivery wins investor approval, bagging Series A

3 years ago

No humans allowed: Alex Zhavoronkov adds robotic lab to his AI drug discovery play as Insilico unveils $60M raise

3 years ago

ARCH-backed Resilience nabs its latest financing round, putting together a massive $625M Series D

3 years ago

All in on early-stage, Qiming US bags $260M, recruits Atara founder Isaac Ciechanover for Fund III

3 years ago

The target is the system: Condensates biotech aspires to ‘rewrite the rulebook’ on drug discovery

3 years ago

Santhera renegotiates milestone payment, increases liquidity runway into 2023 pending NDA filing

3 years ago

Precision drug + diagnostics biotech scores modest Series A, retrofitting existing drug for new indication

3 years ago

Samantha Truex officially unwraps Upstream Bio, her secretive, OrbiMed-backed biotech with $200M in the bank

3 years ago

Peptide biotech gets renewed support from Bristol Myers, others to bankroll multiple oncology clinical programs

3 years ago

Sequoia China leads $37M infusion into radiopharmaceuticals player setting up shop in China and Belgium

3 years ago

Two years post-stealth exit, highly secretive inflammation biotech secures final tranche of Series A round

3 years ago

Flagship's latest biotech could turn some of the thousands of new proteins it discovered into therapies — and it has $75M to start

3 years ago

While down 87% YOY, Evelo gets Flagship and others to infuse new capital for comeback hope

3 years ago

Former Principia team looks to shake up covalent small molecules again, this time at 'earthquake' scale

3 years ago

A new spinout wades into ovarian aging, armed with a seed round and experimental drugs from Mass General

3 years ago

Scoop: After pulling IPO ambitions last December, Jeff Aronin's Castle Creek turns to private backers

3 years ago

Maryland offers loan to Clene despite ALS trial bumps

3 years ago

Not one, not two, but three — biotech claims it will pursue CARs T, M and NK all at once

3 years ago

After laying off a fourth of its staff, gene therapy startup SwanBio sees fresh financing as it heads towards the clinic

3 years ago

First page Previous page 53 54 555657 58 59 Next page Last page